Virpax's matthew barnes to present at outsourcing in clinical trials conference

Berwyn, pa.--(business wire)--virpax pharmaceuticals, inc. (nasdaq: vrpx) (“virpax” or the “company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (cns) disorders and anti-viral barrier indications, is pleased to announce its senior director of portfolio management, matthew barnes, will be presenting at outsourcing in clinical trial conference. the outsourcing in clinical trials (oct) is a leading confer.
B Ratings Summary
B Quant Ranking